Classification of Heart Failure With Preserved Ejection Fraction



Status:Active, not recruiting
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:21 - Any
Updated:4/17/2018
Start Date:July 2008
End Date:December 2020

Use our guide to learn which trials are right for you!

Etiologic, Pathophysiologic, and Genetic Classification of Heart Failure With Preserved Ejection Fraction

The purpose of this study is to create a classification system for the heterogenous disorder
of heart failure with preserved ejection fraction (HFpEF).

Patients with HFpEF are a heterogeneous group with varying etiology and pathophysiology,
which may play a large role in the difficulty in managing these patients and enrolling them
in clinical trials. A major advance in the care of patients with HFpEF would be a
classification system based on etiology, pathophysiology, and/or genetic factors as well as
machine learning analyses. The ultimate goal of this study is to demonstrate that it is
possible to better classify patients with HFpEF based on etiologic, pathophysiologic, and
genetic differences between patients. If successful, this study could lead to: (1) novel risk
estimation in patients with HFpEF and (2) more fruitful clinical trials based on targeting
specific subsets of HFpEF.

Inclusion Criteria:

- Age > 21 years

- Signs or symptoms of congestive heart failure

- Left ventricular ejection fraction > 50%

Exclusion Criteria:

- Severe valvular heart disease

- History of cardiac transplantation

- Prior history of heart failure associated with left ventricular ejection fraction <
35%
We found this trial at
1
site
303 E Chicago Ave
Chicago, Illinois 60611
(312) 503-8194
Northwestern University Feinberg School of Medicine Northwestern University Feinberg School of Medicine, founded in 1859,...
?
mi
from
Chicago, IL
Click here to add this to my saved trials